GetTopicDetailResponse(id=710c411926b, topicName=圖卡替尼, introduction=圖卡替尼, content=null, image=null, comments=0, allHits=996, url=https://h5.medsci.cn/topic?id=41192, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=99770, tagList=[TagDto(tagId=99770, tagName=圖卡替尼)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2249165, encodeId=7336224916544, content=<a href='/topic/show?id=cbef6022e4c' target=_blank style='color:#2F92EE;'>#曲妥珠單抗#</a> <a href='/topic/show?id=710c411926b' target=_blank style='color:#2F92EE;'>#圖卡替尼#</a> <a href='/topic/show?id=69b812358439' target=_blank style='color:#2F92EE;'>#HER2突變乳腺癌#</a>, objectTitle=Nat. Med | 圖卡替尼聯(lián)合曲妥珠單抗治療HER2突變晚期乳腺癌：療效顯著與良好耐受性, objectType=article, longId=860540, objectId=2fbc86054051, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241113/1731488394542_8538692.png, objectUrl=/article/show_article.do?id=2fbc86054051, replyNumber=0, likeNumber=0, createdTime=2025-01-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=2fbc86054051, moduleTitle=Nat. Med | 圖卡替尼聯(lián)合曲妥珠單抗治療HER2突變晚期乳腺癌：療效顯著與良好耐受性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2fbc86054051)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197926, encodeId=14a3219e92657, content=<a href='/topic/show?id=324493404ae' target=_blank style='color:#2F92EE;'>#轉移性乳腺癌#</a> <a href='/topic/show?id=710c411926b' target=_blank style='color:#2F92EE;'>#圖卡替尼#</a> <a href='/topic/show?id=897f10555688' target=_blank style='color:#2F92EE;'>#德喜曲妥珠單抗#</a>, objectTitle=JAMA NETW OPEN | ERBB2陽性轉移性乳腺癌患者接受德喜曲妥珠單抗后接受圖卡替尼聯(lián)合治療的效果觀察, objectType=article, longId=821089, objectId=ec0a82108929, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240410/1712759612754_6145188.jpg, objectUrl=/article/show_article.do?id=ec0a82108929, replyNumber=0, likeNumber=96, createdTime=2024-04-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ec0a82108929, moduleTitle=JAMA NETW OPEN | ERBB2陽性轉移性乳腺癌患者接受德喜曲妥珠單抗后接受圖卡替尼聯(lián)合治療的效果觀察, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ec0a82108929)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
